$DYAI Dyadic to Report Full Year 2023 Financial Re
Post# of 98044
(Total Views: 107)
Posted On: 03/15/2024 9:42:00 AM
$DYAI Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
https://www.globenewswire.com/news-release/20...-2024.html
JUPITER, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused building innovative microbial protein production platforms to address the growing demand for global protein bioproduction utilizing its advanced microbial platforms to develop and manufacture prophylactic, therapeutic, and nutritional biopharmaceutical products for human and animal health and wellness, today announced that it will report its financial results for the year ended 2023 and host a corporate update conference call on Thursday, March 28, 2024.
Conference Call Information
Date: Thursday, March 28, 2024
Time: 5:00 p.m. Eastern Time
Dial-in numbers: Toll Free: 877-407-0784; International +1-201-689-8560
Conference ID: 1650830
Webcast Link: https://viavid.webcasts.com/starthere.jsp?ei=...065a3e040c. An archive of the webcast will be available within 24 hours after completion of the live event and will be accessible on the Investor Relations section of the Company's website at www.dyadic.com. To access the replay of the webcast, please follow the webcast link above.
If you have any questions that you would like to ask management during the Q&A session, please email hzosiak@dyadic.com prior to the conference call.
https://www.globenewswire.com/news-release/20...-2024.html
JUPITER, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused building innovative microbial protein production platforms to address the growing demand for global protein bioproduction utilizing its advanced microbial platforms to develop and manufacture prophylactic, therapeutic, and nutritional biopharmaceutical products for human and animal health and wellness, today announced that it will report its financial results for the year ended 2023 and host a corporate update conference call on Thursday, March 28, 2024.
Conference Call Information
Date: Thursday, March 28, 2024
Time: 5:00 p.m. Eastern Time
Dial-in numbers: Toll Free: 877-407-0784; International +1-201-689-8560
Conference ID: 1650830
Webcast Link: https://viavid.webcasts.com/starthere.jsp?ei=...065a3e040c. An archive of the webcast will be available within 24 hours after completion of the live event and will be accessible on the Investor Relations section of the Company's website at www.dyadic.com. To access the replay of the webcast, please follow the webcast link above.
If you have any questions that you would like to ask management during the Q&A session, please email hzosiak@dyadic.com prior to the conference call.
(0)
(0)Scroll down for more posts ▼